ArticleInternational journal of clinical and experimental pathology2023

Lenvatinib plus Immune Checkpoint Inhibitors versus Lenvatinib monotherapy as treatment for advanced hepatocellular carcinoma: a meta-analysis.

Xinlin Yu et al.PubMed ↗Full text ↗

No numbers read from the abstract.